n
a
v
Portfolio
Genetics
AmplideX® PCR/CE FMR1
AmplideX® mPCR FMR1
AmplideX® FMR1 Controls
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
AmplideX® PCR/CE
SMN1
Kit
AmplideX® PCR/CE
SMN1/2
Kit
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
HTT
Kit
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
QuantideX® NGS RNA Lung Cancer Kit
QuantideX® NGS DNA Hotspot 21 Kit
Custom & Companion Diagnostics
Commercialization
Product Approval
Development
Discovery
Partnered R&D
Tumor Bank
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Tumor Bank
Custom Reagents
Armored Reagents
In Vitro
Transcribed RNA
Plasmid DNA
Companion Diagnostics
Commercialization
Product Approval
Development
Discovery
Partnered R&D
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X
Leukemia
Dementia
Other Resources
Videos
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
About
Leadership Team
Culture and Heritage
Press Releases
Upcoming Events
Business Development
Contact
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2020
2019
2018
2017
2016
2015
2014
2013
2012
March 16, 2020
Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control
Share
February 24, 2020
FDA Grants Premarket Clearance of Asuragen’s AmplideX® Fragile X Dx and Carrier Screen Kit
Share
November 25, 2019
Asuragen Partners with Wave Life Sciences to Develop Companion Diagnostics for Huntington’s Disease
Share
November 6, 2019
Asuragen Announces Launch of AmplideX® PCR/CE SMN1/2 Plus Kit
Share
October 30, 2019
Asuragen to Present at 2019 Association for Molecular Pathology (AMP) Annual Meeting
Share
October 8, 2019
Asuragen to Present at the 2019 American Society of Human Genetics (ASHG) Annual Meeting
Share
June 11, 2019
Asuragen to Present at 2019 European Society of Human Genetics (ESHG) Conference
Share
June 4, 2019
Asuragen NGS System Streamlines Detection of NSCLC-associated DNA Mutations, Gene Fusions, and RNA Expression Targets in Single Workflow
Share
April 2, 2019
Asuragen Releases Updated AmplideX® PCR/CE Reporter Software
Share
March 26, 2019
Asuragen to Present at 2019 ACMG Annual Clinical Genetics Meeting
Share
1
2
3
4
5
6
7
Next
About
About
Leadership Team
Board of Directors
Culture and Heritage
Press Releases
Upcoming Events
Business Development
Back To
Top
